Record current through

Who really controls medicine?

Hospitals decide privileges. Boards decide licences. Insurers decide coverage. Employers control access to work. Courts decide disputes. Legislatures write the rules. Algorithms increasingly influence all of them.

KPSGILL follows the decisions, the evidence and the consequences — healthcare law, regulation, clinical practice and institutional power, connected through primary documents.

276 policy analyses · 140 patient guides · 8 living dossiers · hundreds of primary-source-linked records

Representative illustration: a physician seen from behind, with a hospital corridor, the California State Capitol, a regulatory hearing room and a policy analyst’s data screens arranged around them. The people and institutions shown are not real.
Living dossier · leadIn force · argued · not decided

The CDL crackdown: what changed for non-citizen truck drivers

  • In force. A federal rule effective 16 March 2026 limits non-domiciled commercial licences to H-2A, H-2B and E-2 status; FMCSA estimates about 194,000 current holders lose eligibility as credentials expire.
  • In court. Rivera Lujan v. FMCSA was argued 15 September and California’s funding case 11 September. Neither is decided.
  • Who carries it. The Sikh Coalition says about a third of California’s truck drivers are Sikh; a Punjabi trucking association estimates 130,000–150,000 U.S. drivers come from Punjab and Haryana.

What this is and is not. A record of licensing law, litigation and documented impact, with the government’s safety rationale and the civil-rights objections side by side, each attributed. It is not a claim that the rule was adopted because of anyone’s religion or national origin, it predicts no outcome, and it names no individual.

Sources: Federal Register 13 Feb 2026 · FMCSA rule FAQs · Sikh Coalition · Land Line · Overdrive · CalMatters

Read the dossier →

Representative illustration. No real person is depicted.

Lead investigation

California · Medi-Cal pharmacy policy

Representative illustration: an analyst reviewing California pharmacy-spending charts and a state map, with GLP-1 injection pens and a pharmacy counter alongside and the State Capitol behind.California Counted What the GLP-1 Benefit Cost. It Has Not Published What the Benefit Did.Medi-Cal paid $416.8 million in 2023, gross of rebates, for GLP-1 prescriptions in a cohort built by excluding identified diabetes — then eliminated weight-loss coverage on cost grounds effective 1 January 2026. No public Medi-Cal outcomes evaluation could be located for any year of the programme, and the Legislature’s own analyst asked DHCS for better cost and rebate reporting while never asking for clinical outcomes at all.ORIGINAL ANALYSISRead the investigation →

Representative editorial illustration of California pharmacy-policy and spending analysis; no real patient or proceeding is depicted.

On the record today

Verified

California signed its first tracked AI measure, federal agencies moved on devices, drugs and dispute infrastructure, and the 2027 Match opened — each at a different point in its own process. An approval is not coverage, a signature is not an effective date, and eight health bills still awaiting the Governor are not law.

Representative illustration: analysts at a regulatory intelligence desk with the California and United States Capitols, European Union institutions and the Palace of Westminster behind them.
Representative illustration · not real people, institutions or events.
CaliforniaSB 813 is lawSigned 9 September: a framework for independent verification organizations to assess AI systems for compliance with state law, alongside AB 1405’s AI auditor registry. Chapter number and operative date are recorded when the chaptered text is read.SignedCaliforniaWildfire smoke now has statutory testing dutiesSigned 15 September: state agencies must set lead and asbestos testing and cleanup standards for smoke-damaged homes, and insurers must cover qualifying testing and remediation. The standards do not yet exist.Signed · standards pendingUnited StatesThe No Surprises dispute portal opens accountsCMS opened IDR Gateway account creation on 15 September; disputes move from web forms in late 2026. This is provider–payer machinery. It changes nothing a patient owes.Account creation openUnited StatesA first muscle-targeted SMA therapyFDA approved Isembyld on 11 September for SMA patients aged 2 and older already on an SMN2-targeted treatment. The label warns of fracture risk. An approval is not a coverage decision.ApprovedUnited StatesAn iron infusion gets FDA’s strongest warningA boxed warning for symptomatic low phosphate with ferric carboxymaltose (Injectafer), with phosphate checks recommended in defined cases. A warning, not a recall.Label changeIMG → U.S.2027 Match registration is openNRMP registration opened 15 September at 12 PM ET. The ECFMG Pathways deadline is 31 January 2027, and ECFMG must report eligibility before the 3 March rank-list deadline.Open

8 comment windows are open right now and 20 dated obligations fall in the next thirty days — every one computed from the record, never typed by hand. See the live desk · the full calendar

Start with these

What brings you here?

Twelve doors into the same body of work. A patient and a regulator are asking different questions about the same decision — so each of these starts where you actually are.

Peer review & credentialing →

Representative illustration: a short viral clip shown on one screen beside the complete recording on another, before a hearing panel. The people, institution and proceeding shown are not real.
The short clip is one exhibit. The complete recording is another. Representative illustration · not real people, institutions or events.
Fictional teaching case

The Video Wasn’t Made for the Hospital

A private off-duty argument becomes a viral recording. No patient was involved. The criminal case is unresolved. Yet hospital privileges, peer review, California reporting, the NPDB and future credentialing can begin converging on the same event.

The hospital faces competing risks: act too quickly, or appear to have ignored a legitimate concern.

11,000-word documented teaching case · California peer review

Read the case study →

Today’s three questions

What changed today

All verified developments →

United StatesArgued 15 Sept · decision pending

A three-judge panel heard the non-domiciled CDL case

Why it matters
Rivera Lujan v. FMCSA, No. 26-1032, tests whether FMCSA acted arbitrarily in withdrawing commercial-licence eligibility from roughly 194,000 holders.

What it does not yet mean
Nothing. Argument is not a ruling. Trade press reported sharp questioning of the agency; that is an account of a hearing, and no outcome is implied.

United StatesLaw · funded through 11 Dec

Federal agencies are funded through 11 December 2026

Why it matters
The continuing appropriations measure was signed 2 September. There is no 30 September funding lapse, and the explainers that carried that date are corrected.

What it does not yet mean
Full-year appropriations, or any change to Medicare, Medicaid or marketplace benefit rules. The next deadline is 11 December.

United StatesState start by 1 Jan 2027

Medicaid community engagement requirements start by January 2027

Why it matters
States must begin applying the requirements to specified populations no later than 1 January 2027 under CMS-2454-IFC.

What it does not yet mean
That any individual loses coverage. Exemptions and verification are set by each state — which makes this a paperwork problem before it is an eligibility problem.

One event. Many systems.

Representative illustration: one case file at the centre of a criminal court, a hospital committee, a credentialing review and a licensing desk, connected by a single thread. No real case is depicted.
Representative illustration · not real people, institutions or events.
  1. 01Criminal court
  2. 02Medical Board
  3. 03Hospital & credentialing
  4. 04Employment & payers
  5. 05Other licensing & reporting consequences

The same underlying event can be evaluated by different institutions, for different purposes, under different legal, evidentiary and institutional decision standards.

Follow the regulatory cascade →

Not the same thing

IndictmentConviction
AccusationDiscipline
SettlementAdmission
Proposed ruleLaw

Why claim type matters →

Follow the power

Representative illustration: the institutions that decide in medicine — board, hospital, insurer and employer — shown connected to one another.
Representative illustration · not real people, institutions or events.

Worth reading

Explore 276 policy analyses →

California now

Open the California desk →

Representative illustration: the California State Capitol with a bill-lifecycle diagram on a tablet, tabbed policy binders and the state flag. No real proceeding is depicted.
Representative illustration · not real people, institutions or events.
Governor’s desk · action deadline 30 September 2026

View all tracked health bills → · Health AI · Medical Board

How medicine actually works

All explainers →

Representative illustration: the administrative corridor behind an ordinary clinical decision — authorisation, credentialing, billing and complaint handling.
Representative illustration · not real people, institutions or events.

IMG → U.S.

Exams are only one part of the pathway. Certification, residency screening, immigration, licensing and institutional filters all matter.

Open the IMG institute →

Representative illustration: a physician with a bag walking a path from a globe and documents toward a hospital entrance. The person and institution shown are not real.

For patients

Open the patient library →

Medicine without the bureaucracy.

140 plain-language guides explaining conditions, medicines, prevention and the healthcare decisions patients actually face.

Representative illustration: a physician talking with a family in a bright consulting room, with everyday prevention — walking, food and medicines — at the edges of the frame.
Representative illustration · not real people, institutions or events.

How we know

How the research works →

Representative illustration: a research desk of statutes, dockets, agency decisions and coded records.
Representative illustration · not real people, institutions or events.
Primary documentsStatutes, regulations, dockets, decisions and official agency records.
Claim type mattersAn allegation is not a finding. A proposal is not law.
The record changesLiving analyses state when they were updated and what changed.

Compiled by Kanwar Partap Singh Gill, MD. Editorial standards · Search

Everyday — Fresno, California, America

The desk →

Medicine, policy, California and everyday American life — documented carefully. The same records practice applied to the documents that land in a Central Valley mailbox: an insurance approval, a wage certification, a heat standard, a bill on the Governor’s desk.

Previously on the record

Retired from the lead grid on 16 September 2026, 2:00 PM PT · kept, not deleted

CaliforniaAwaiting the Governor · deadline 30 Sept

Eight tracked health bills are still not law

Why it matters
SB 503, SB 1023 and SB 942 have been on the Governor’s desk since 30–31 August; AB 2575, AB 1199, SB 903, AB 1979 and AB 539 have passed the Legislature.

What it does not yet mean
None is law today. A bill in the Governor’s possession that is neither signed nor vetoed by 30 September becomes law without signature.

United StatesAdministrative action

CMS barred 11 equipment suppliers from Medicare Advantage and Part D payment

Why it matters
CMS links them to more than $3.4 billion in suspected fraudulent billing, including equipment billed for beneficiaries who had died.

What it does not yet mean
It is not a criminal charge, and the figure is suspected billing, not proven loss.

United StatesAccelerated approval

A breast-cancer drug approved on a blood-test signal, over a negative advisory vote

Why it matters
Camizestrant can be started when an ESR1 mutation appears in circulating tumour DNA, before scans show progression.

What it does not yet mean
Long-term benefit of switching at molecular progression is not established; confirmatory evidence is required.